Tudor Investment Corp’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-174,397
Closed -$85.5K 3006
2023
Q2
$85.5K Sell
174,397
-20,600
-11% -$16.9K ﹤0.01% 2303
2023
Q1
$226K Buy
194,997
+23,301
+14% +$42.6K ﹤0.01% 2105
2022
Q4
$460K Buy
171,696
+1,526
+0.9% +$4.02K 0.01% 1637
2022
Q3
$487K Buy
170,170
+35,493
+26% +$151K 0.01% 1419
2022
Q2
$669K Buy
134,677
+55,089
+69% +$289K 0.02% 1110
2022
Q1
$566K Buy
+79,588
New +$658K 0.01% 1200
2020
Q4
Sell
-5,909
Closed -$451K 1710
2020
Q3
$451K Buy
+5,909
New +$375K 0.02% 860

Other funds holding CELL

Tudor Investment Corp's CELL Position: Q3 2023 in Review

Tudor Investment Corp sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 174,397 shares — an estimated $85.5K sold.

Tudor Investment Corp first reported a position in CELL in Q3 2020 and held it in 7 quarters. The position peaked at $669K in Q2 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Tudor Investment Corp reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 174,397 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $85.5K.
  • Tudor Investment Corp first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Tudor Investment Corp's PhenomeX Inc. Common Stock position peaked at $669K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Tudor Investment Corp's 13F filing for Q3 2023, filed 15 Nov 2023.